Santoni v. Schaerf

428 A.2d 94, 48 Md. App. 498, 1981 Md. App. LEXIS 256
CourtCourt of Special Appeals of Maryland
DecidedApril 14, 1981
Docket1187, September Term, 1980
StatusPublished
Cited by14 cases

This text of 428 A.2d 94 (Santoni v. Schaerf) is published on Counsel Stack Legal Research, covering Court of Special Appeals of Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Santoni v. Schaerf, 428 A.2d 94, 48 Md. App. 498, 1981 Md. App. LEXIS 256 (Md. Ct. App. 1981).

Opinion

Moylan, J.,

delivered the opinion of the Court.

Mario Santoni, age 56, died on July 3, 1972, of hepatitis caused by his taking of the drug isoniazid (INH). The drug was dispensed to him in a tuberculosis prevention program conducted by the Baltimore City Health Department. As a result, on April 29,1975, Antoinette Santoni, his widow and the personal representative of his estate, brought a medical malpractice suit under the wrongful death statute against Dr. Allan S. Moodie, Director of the Bureau of Communicable Diseases of the Baltimore City Health Department and head of the Baltimore City tuberculosis program; Dr. Meyer W. Jacobson, Clinical Director of the Baltimore City tuberculosis program; and Dr. Herman Schaerf, a clinical doctor *500 in the Baltimore City tuberculosis program. 1 A trial of the case was held in the Superior Court of Baltimore City in February, 1980. The trial consumed more than two weeks and involved the testimony of thirteen witnesses. The case was eventually submitted to the jury on the issues of the defendants’ negligence and the decedent’s contributory negligence. On February 29, 1980, a jury rendered a verdict finding no negligence on the part of Dr. Schaerf which caused or contributed to the decedent’s death but negligence on the parts of Drs. Moodie and Jacobson. The jury also found, however, that the decedent’s own negligence caused or contributed to his death, thereby barring recovery by the plaintiff. After Mrs. Santoni’s motion for judgment n.o.v. and for a partial new trial or a new trial was denied, she filed this appeal. The defendants have filed a cross-appeal.

On this appeal, the appellant raises the following contentions:

1) That the decedent was not contributorily negligent as a matter of law and that the trial court, therefore, erred in permitting the question of his contributory negligence to go to the jury;
2) That the trial court erred in its instructions on contributory negligence;
3) That the trial court committed reversible error in refusing to admit into evidence a certain conversation between the appellant and her husband;
4) That the trial court committed reversible error in admitting into evidence a "Danger Signs” poster; and
5) That the jury’s verdict was inconsistent and irreconcilable..

The defendant-appellees, on the other hand, in their cross-appeal contend that their motions for a directed verdict *501 on the issue of immunity should have been granted. They also contend that the court erred in admitting evidence of twelve other deaths of persons who received INH therapy from the Baltimore City Health Department.

The drug isoniazid (INH) has been used since the early 1950’s for the prevention and treatment of tuberculosis. Its metabolism is by the liver. Until the mid-1960’s, it was thought to be one of the safest drugs on the market. In 1970, however, after two men who were participants in a tuberculosis prevention program in Washington, D.C., died from hepatitis, it was recognized that the ingestion of INH might be associated with liver disease, particularly hepatitis. As a result, in 1971, the United States Public Health Service recommended that certain screening and monitoring procedures be used on all recipients of the drug in any INH program. The Service also recommended that a study be made of persons taking INH to determine if there were any connection between the INH and liver disease. Following up on its recommendation of a surveillance program, the Public Health Service sought to enlist the help of local health departments to report on the progress of patients in local health department INPI programs. The Service would keep the statistical information, while the local public health agencies would dispense the drug and monitor the people. Baltimore City at that time and for many years before had one of the highest tuberculosis rates in the country, both in number of cases and deaths. In order to expand its already existing prophylaxis program the Baltimore City Health Department agreed to participate in the special surveillance program.

The protocol for the surveillance program promulgated by the United States Public Health Service called for dispensing the drug, in pill form, only on a monthly basis. A patient would thus be required to return to the clinic once a month to receive his 30-day supply of pills. At the time of these visits, any adverse reactions would be noted, particularly any possible signs and symptoms of hepatitis. The protocol provided that the participant would be "ask[ed] specifically about jaundice, dark urine, sustained loss of *502 appetite, marked fatigue and prolonged nausea or vomiting.” In any cases of suspected hepatitis, the isoniazid would be discontinued immediately. A monthly report card would be sent to the Public Health Service on each patient.

In 1972, Dr. Allan S. Moodie was the Administrative Health Officer in the Baltimore City Health Department in charge of the administrative aspects of the isoniazid program such as arranging funding and staff for the program. He arranged for the Baltimore City Health Department to participate in the United States Public Health Service surveillance program. Dr. Meyer W. Jacobson was the Clinical Director of the Baltimore City tuberculosis program. Eventually approximately 3,000 persons entered the surveillance program.

The program in Baltimore City provided that a clinic doctor would make the determination whether a person would be placed on INH therapy, based on the tuberculin skin test and chest X-ray. Thereafter, a nurse would instruct the patient on the use of the drug and any signs and symptoms of a reaction. At the follow-up monthly visits, at first only public health nurses were permitted to interview the participants in the program. As the program expanded, however, health aides and clerical help were authorized to conduct the interviews. If a patient reported any side effects, the patient was to be referred to a clinic doctor for further examination. Any reaction to the drug was to be reported on a chemoprophylaxis register sheet and on the computer cards sent monthly to the Public Health Service.

Mario Santoni became a participant in the Baltimore City isoniazid program in 1972. Mr. Santoni, a native of Italy, came to the United States in 1955. Two years later, he married the appellant, Antoinette Santoni. In Italy, Mr. Santoni had completed only the fourth or fifth grade and, in this country, worked primarily as a painter and carpenter. In 1972, he spoke only broken English and had great difficulty reading it. Prior to the illness which caused his death, his health had been excellent and, according to his wife, he had never been to a doctor for any illness.

*503 In January, 1972, Mr. Santoni became a naturalized citizen of the United States and also became employed by Baltimore City as a maintenance man at the Southern District Police Station. As a prerequisite to his employment, he was required to undergo a medical examination with a tuberculin skin test and chest X-ray.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cador v. YES Organic Market
Court of Special Appeals of Maryland, 2022
Penn Harris Madison School Corp. v. Howard
832 N.E.2d 1013 (Indiana Court of Appeals, 2005)
Hopkins v. Silber
785 A.2d 806 (Court of Special Appeals of Maryland, 2001)
Simmons v. Urquhart
664 A.2d 27 (Court of Special Appeals of Maryland, 1995)
Robinson v. Washington Internal Medicine Associates, P.C.
647 A.2d 1140 (District of Columbia Court of Appeals, 1994)
Wegad v. Howard Street Jewelers, Inc.
605 A.2d 123 (Court of Appeals of Maryland, 1992)
Coates v. State
600 A.2d 856 (Court of Special Appeals of Maryland, 1992)
Howard Street Jewelers, Inc. v. Wegad
589 A.2d 1285 (Court of Special Appeals of Maryland, 1991)
Cheek v. Domingo
628 F. Supp. 149 (Virgin Islands, 1986)
Santoni v. Moodie
452 A.2d 1223 (Court of Special Appeals of Maryland, 1982)
Moodie v. Santoni
292 Md. 582 (Court of Appeals of Maryland, 1982)

Cite This Page — Counsel Stack

Bluebook (online)
428 A.2d 94, 48 Md. App. 498, 1981 Md. App. LEXIS 256, Counsel Stack Legal Research, https://law.counselstack.com/opinion/santoni-v-schaerf-mdctspecapp-1981.